• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Auddia Announces Non-binding Letter of Intent for Business Combination and Restructuring

    8/5/25 6:00:00 AM ET
    $ACON
    $AUUD
    Medical Specialities
    Health Care
    EDP Services
    Technology
    Get the next $ACON alert in real time by email

    Restructuring into a holding company focused on delivering AI and web3 efficiencies to portfolio companies

    AI efficiencies include discounted AI compute costs, centralized AI model training and engineering, and utilization of AI tools to optimize operations

    Web3 efficiencies include leveraging treasury strategies and the development of new blockchains and tokens to reinvent market verticals, optimize portfolio company operations, and drive sustainable multiples of NAV  

    BOULDER, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), today announced that in follow up to the leadership and strategic changes announced last month the Company's Board, acting upon the recommendation of the Special Committee of Independent Directors, has approved a non-binding letter of intent ("LOI") for a business combination between Auddia and Thramann Holdings, LLC ("Holdings").

    Holdings is a privately held holding company that controls LT350, Influence Healthcare, and Voyex, three early stage AI-native companies founded by Jeff Thramann. Thramann is a serial entrepreneur and inventor named on over 130 U.S. and international patents. He has taken Auddia and Aclarion (NASDAQ:ACON) public, sold Lanx and US Radiosurgery to public companies, sold ProNerve and American Physicians to private equity, and sold Denver CyberKnife to a private company. Thramann is the founder of each of these companies except Aclarion.

    "As an innovator, I have spent the past 15 years securing patents in the AI infrastructure space, immersing myself in both the development and use of AI models, and developing blockchain and digital currency strategies aimed at empowering the value drivers of industries to reinvent their markets," said Jeff Thramann, founder, Chairman, and CEO of Auddia. "I believe there is an incredible opportunity for a holding company at the juncture of AI and web3 to harness these technologies and deliver them to portfolio companies."

    The LOI contemplates a business combination between Auddia and Holdings with Auddia becoming a public holding company trading under a new name and ticker symbol. The transaction would result in the portfolio companies of Holding and Auddia becoming subsidiaries of the public holding company.

    Under the proposed terms, Holdings' equity holders are expected to receive an 80% ownership interest in the combined company, with Auddia equity holders owning a 20% interest.

    Following closing of the business combination, the holding company's board of directors will initially consist of Auddia's current board of directors, who expect to appoint a new CEO for the Auddia business. Jeff Thramann, Auddia's current CEO, will continue as CEO of the public holding company while John Mahoney, Auddia's current CFO, will continue in his position as CFO of the public holding company and oversee the finances of all subsidiaries.

    The business combination is a related party transaction. Jeff Thramann, the founder, Chairman, and CEO of Auddia is also the founder and majority shareholder of Holdings. As previously disclosed, to mitigate the conflicts inherent in related party transactions, in July 2025 the Auddia board formed a Special Committee of Independent Directors, who were represented by independent counsel in their consideration of the proposed business combination. Jeff Thramann did not participate in the deliberations of the Special Committee regarding the proposed business combination. Mr. Thramann also was recused from the board vote approving the Special Committee's recommendation to proceed with executing the non-binding LOI for the proposed business combination. The Special Committee expects to engage an investment bank to serve as its financial advisor and provide a fairness opinion on the proposed business combination. The parties intend to negotiate a definitive business combination agreement that incorporates the provisions of the LOI as well as other terms and conditions typical for transactions of this nature.

    The parties have agreed to a 30-day exclusivity period to negotiate a definitive business combination agreement, which will include customary closing conditions such as board and stockholder approvals, regulatory approvals, effectiveness of a registration statement relating to the issuance of Auddia common stock in the business combination and continued listing of the combined company's common stock on Nasdaq. Closing will also be conditioned on Auddia raising at least $10 million of additional capital to fund ongoing business operations of Auddia and the combined business.

    The Company will provide an update on the new operating plan of Auddia in the coming weeks, as well as details related to the operating companies within Holdings.

    The proposed business combination is subject to a number of known and unknown risk and uncertainties. There can be no assurances that the parties will enter into a definitive business combination on the terms contemplated hereby or at all. Further, there can be no assurances that such business combination will be approved by stockholders or will ultimately be consummated.

    About Thramann Holdings, LLC

    Thramann Holdings is a holding company that controls LT350, Influence Healthcare, and Voyex, three AI native operating companies.

    LT350 is a distributed AI data center company with 9 issued patents on a proprietary solar parking lot canopy that turns any parking lot into an AI data center. The Company has a strategic partnership with a top ten convenience store gas station brand that includes an equity investment and development of a pilot convenience store gas station. The partnership holds the potential to deploy the world's largest distributed AI data center at the lowest possible cost by replacing existing gas station canopies with LT350 canopies.

    Influence Healthcare is a value based care provider leveraging AI, blockchain, and vertical integration to empower surgeons to drive adoption of value based care to the surgical specialties.

    Voyex is an agentic AI company addressing flight delays and cancellations, which are the largest pain points for air travelers.

    About Auddia Inc.

    Auddia, through its proprietary AI platform for audio identification and classification, is reinventing how consumers engage with AM/FM radio, podcasts, and other audio content. Auddia's flagship audio superapp, called faidr, brings multiple industry firsts to the audio streaming landscape that include:

    • subscription based, ad free listening on any AM/FM radio station
    • content skipping across any AM/FM station
    • one touch skipping of entire podcast ad breaks
    • subscription based, ad free listening to podcast partners

    faidr also delivers exclusive content and playlists, and showcases exciting new artists, hand-picked by curators and DJs. For more information, visit: www.auddia.com

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Company's current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as "anticipates," "believes" and "expects" or similar expressions, are forward-looking statements. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. These and other risks and uncertainties are discussed more fully in our filings with the Securities and Exchange Commission. Readers are encouraged to review the section titled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, as well as other disclosures contained in the Annual Report and subsequent filings made with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    Investor Relations:

    Kirin Smith, President

    PCG Advisory, Inc.

    [email protected]

    www.pcgadvisory.com



    Primary Logo

    Get the next $ACON alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $AUUD

    CompanyDatePrice TargetRatingAnalyst
    Auddia Inc.
    $AUUD
    9/16/2021$9.00Buy
    Maxim Group
    More analyst ratings

    $ACON
    $AUUD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aclarion Wins "Rising Star" at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH

    Company previously announced it was selected as a finalist from more than 1,800 submissions Award win underscores growing impact of Aclarion's breakthrough Nociscan solution for chronic low back pain BROOMFIELD, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced it was named a Rising Star in the Clinical Diagnostic Device category during the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH. The Digital Hea

    10/22/25 6:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    Auddia Announces New Corporate Overview on Company Website

    Webcast Scheduled at LD Micro Conference on Tuesday, October 21, 2025 at 2:00 PM PT Overview reflects previously announced proposals to restructure Auddia as a holding company delivering AI and web3 capabilities to portfolio companies as well as details of the B2B business model pivot for faidr McCarthy Finney (NASDAQ:MCFN) identified as the name of the surviving public company assuming closing of the proposed business combination Company name honors John McCarthy, the father of AI, and Hal Finney, the father of digital currency    BOULDER, Colo., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), a technology company that has built

    10/16/25 6:00:00 AM ET
    $AUUD
    EDP Services
    Technology

    Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst

    Debt-free balance sheet with $13.3 million in cash as of today ($15.11 per share fully diluted) providing strategic flexibility for continued commercial growth Nociscan scan volumes increase +89% year-over-year with third consecutive quarter of record utilization across U.S., U.K., and E.U. markets CLARITY pivotal trial progressing on schedule and early 3-month readouts expected Q2 2026 as AI-driven disc pain biomarker validation continues Webcast scheduled for October 20th at 12:00 pm PT at the LD Micro Main Event BROOMFIELD, Colo., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company th

    10/14/25 6:09:47 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $AUUD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on Auddia with a new price target

    Maxim Group initiated coverage of Auddia with a rating of Buy and set a new price target of $9.00

    9/16/21 10:03:45 AM ET
    $AUUD
    EDP Services
    Technology

    $ACON
    $AUUD
    SEC Filings

    View All

    Auddia Inc. filed SEC Form 8-K: Other Events

    8-K - AUDDIA INC. (0001554818) (Filer)

    10/20/25 5:00:56 PM ET
    $AUUD
    EDP Services
    Technology

    Auddia Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AUDDIA INC. (0001554818) (Filer)

    10/16/25 5:00:29 PM ET
    $AUUD
    EDP Services
    Technology

    Aclarion Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Aclarion, Inc. (0001635077) (Filer)

    10/14/25 6:05:37 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $AUUD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Sroge Joshua Adam

    4 - AUDDIA INC. (0001554818) (Issuer)

    9/12/25 5:00:12 PM ET
    $AUUD
    EDP Services
    Technology

    SEC Form 4 filed by Chief Financial Officer Mahoney John Edward

    4 - AUDDIA INC. (0001554818) (Issuer)

    9/12/25 5:00:06 PM ET
    $AUUD
    EDP Services
    Technology

    SEC Form 4 filed by Executive Chairman and CEO Thramann Jeffrey John

    4 - AUDDIA INC. (0001554818) (Issuer)

    9/12/25 5:00:10 PM ET
    $AUUD
    EDP Services
    Technology

    $ACON
    $AUUD
    Leadership Updates

    Live Leadership Updates

    View All

    Aclarion Appoints Greg Gould as Chief Financial Officer

    HealthTech CFO with extensive public company experience building organizations for growth and value creation Demonstrated success in raising capital, driving profitability, and scaling operations to $500M revenue while ensuring compliance and strengthening financial integrity BROOMFIELD, Colo., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced the appointment of Greg Gould as Chief Financial Officer (CFO), effective immediately. Greg brings mor

    9/3/25 6:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    Auddia Announces Restructuring of Engineering Team in Preparation for Business Combination

    Restructuring projected to reduce engineering costs by $750,000 annually Current lead AI engineer to join the AI engineering team at the holding company level upon closing of the proposed business combination Utilization of internal and dedicated outsourced engineering talent expected to significantly increase the speed of product development BOULDER, Colo., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), an AI first technology company that has built a proprietary AI platform for audio identification and classification to reinvent how consumers engage with audio, today announced a restructuring of its engineering team aimed at si

    8/25/25 6:12:00 AM ET
    $AUUD
    EDP Services
    Technology

    Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

    CLUE is a Multi-center Trial to Identify how Often Nociscan's AI Data Changes the Initial Treatment Plan for Patients With Chronic Low Back Pain Dr. Justin Kubeck Will Initiate CLUE in New Jersey at Ocean Pain and Spine in Toms River BROOMFIELD, CO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW))), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today the expansion of the multi-center CLUE Trial to New Jersey. Justin Kubeck, MD, orthopedic spine surgeon and founder of Ocean Pain and Spine in Toms

    8/29/24 6:57:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $AUUD
    Financials

    Live finance-specific insights

    View All

    Auddia Provides Corporate Update and Investor Call Today

    Providing Forward Looking Guidance on User Metrics and Revenue for the First Time as the Company Transitions From Pre-Revenue to Revenue Generating in 2023 Investor Call and Webcast at 10:30 AM ET Today BOULDER, CO, Nov. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), developer of a proprietary AI platform for audio and innovative technologies for podcasts that is reinventing how consumers engage with audio, today provided a corporate update, and will hold an investor call and webcast at 10:30 am ET today. Jeff Thramann, founder and executive chairman, stated, "We are excited to provide this corporate update as we ach

    11/15/22 7:00:00 AM ET
    $AUUD
    EDP Services
    Technology

    Auddia Inc. Announces Corporate Update Call and Webcast on November 15th

    BOULDER, CO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), developer of a proprietary AI platform for audio and innovative technologies for podcasts that is reinventing how consumers engage with radio, today announced that it will host a corporate update call and investor webcast on Tuesday, November 15th at 10:30 am ET. Participants may dial into the call as follows: Domestic access: 1-877-270-2148 International access: 1-412-902-6510 Upon joining, please ask to be joined into the Auddia Inc. conference call. Participants may also access the live webcast by clicking the following link: https://event.chorusc

    11/8/22 7:00:00 AM ET
    $AUUD
    EDP Services
    Technology

    $ACON
    $AUUD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Aclarion Inc.

    SC 13G/A - Aclarion, Inc. (0001635077) (Subject)

    11/13/24 3:06:29 PM ET
    $ACON
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Aclarion Inc.

    SC 13G - Aclarion, Inc. (0001635077) (Subject)

    9/5/24 4:19:39 PM ET
    $ACON
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Aclarion Inc. (Amendment)

    SC 13G/A - Aclarion, Inc. (0001635077) (Subject)

    3/29/24 5:00:57 PM ET
    $ACON
    Medical Specialities
    Health Care